Navigation Links
FDA's Office of New Drugs Meets With Cell Therapeutics on its Appeal on Pixantrone
Date:3/3/2011

mechanism for anthracycline induced acute cardiotoxicity.  These novel pharmacologic differences may allow re-introduction of anthracycline like potency in the treatment of relapsed/refractory aggressive lymphoma without unacceptable rates of cardiotoxicity.

About Cell Therapeutics, Inc.Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable.  For additional information, please visit www.CellTherapeutics.com.

Sign up for email alerts and get RSS feeds at our Web site, http://www.CellTherapeutics.com/investors_alert

This press release includes forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results and the market price of CTI's securities.  Specifically, the risks and uncertainties that could affect the development of pixantrone include risks associated with preclinical and clinical developments in the biopharmaceutical industry, in general, and with pixantrone, in particular, including, without limitation, the potential failure of pixantrone to prove safe and effective for the treatment of relapsed or refractory aggressive NHL and/or other tumors as determined by the FDA and/or the EMA, that the FDA may request additional clinical trials, that if CTI conducts an additional clinical trial, it may not demonstrate the safety and effectiveness of pixantrone, that CTI cannot predict or guarantee the pace or geography of enrollment of its clinical trials, that CTI may not initiate a new clinical trial for pixantrone in 2011, that CTI cannot predict the outcome of the formal dispute resolution process, that the FDA may not make its decision on the appeal in the second quarter of 2011, that CTI's appeal may not b
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. PDL BioPharma Announces European Patent Office Determination of Validity of PDLs European Patent is Final
2. Thomas, McNerney & Partners Expands Team and Moves West Coast Office to San Diego
3. Masters Pharmaceutical, Inc. Appoints Wayne A. Corona to President and Chief Operating Officer
4. ERT Announces the Appointment of Eric Schwartz as Chief Legal Officer
5. Siemens Appoints Overhage as New Chief Medical Informatics Officer
6. Dr. Jeffrey Freitag Appointed Chief Medical Officer of PharmaNet
7. AVANIR Pharmaceuticals Appoints Gregory J. Flesher to Senior Vice President and Chief Business Officer
8. Orexigen® Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer
9. Baxano, Inc. Names George A. Harter, Jr. as Chief Financial Officer
10. Arena Pharmaceuticals Announces Upcoming Departure of Chief Financial Officer
11. 3-V Biosciences Promotes Stephen R. Brady to Chief Business Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... -- Anpac Bio-Medical Science Co., Ltd., Chief Executive Officer and ... research team are introducing what the 2015 Nobel Prize ... "game changing" and "breakthrough" early cancer detection technology research ... Annual Meeting in Chicago, Illinois , ... An accomplished inventor with over 200 patent applications (100 ...
(Date:5/29/2015)... , May 29, 2015 Actinobac Biomed, ... originally funded with investments from Foundation Venture Capital Group ... Bio International 2015 as part of the Start-Up Stadium ... FVCG President James M. Golubieski . ... biotechnology industry, will be held in Philadelphia ...
(Date:5/29/2015)... 28, 2015 Research and Markets ( ... PharmaBiotech,s new report "Cardiovascular Drug Delivery - ... Drug delivery to the cardiovascular system ... of the anatomy and physiology of the vascular ... organs of the body. Drugs can be introduced ...
Breaking Medicine Technology:Anpac Bio-Medical Introduces 'Game Changing' Cancer Screening Tech at American Society of Clinical Oncology Meeting - Chicago 5/29 - 6/2 2Anpac Bio-Medical Introduces 'Game Changing' Cancer Screening Tech at American Society of Clinical Oncology Meeting - Chicago 5/29 - 6/2 3Foundation Venture Capital Group Portfolio Companies to be Highlighted at Bio International in June 2Foundation Venture Capital Group Portfolio Companies to be Highlighted at Bio International in June 3Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies 2Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies 3
... (NYSE Amex: CXM ) today announced that ... shares of its common stock in a registered direct ... deducting placement agent,s fees and estimated offering expenses. The ... purchased the shares at a price of $0.28 per ...
... Mass., Feb. 16, 2012  Idenix Pharmaceuticals, Inc. (NASDAQ: ... results for the fourth quarter and year end 2011 on ... Idenix management will host a conference call at ... the company,s financial results for the fourth quarter and year ...
Cached Medicine Technology:Cardium Announces Closing of $5.0 Million Equity Financing 2Cardium Announces Closing of $5.0 Million Equity Financing 3
(Date:5/29/2015)... FL (PRWEB) May 29, 2015 According to ... one in 10 full-time workers has a substance abuse problem ... from more than 111,500 adults with full-time jobs, revealed that ... in the previous year. (1) The National Council on Alcoholism ... billion per year, and an estimated 70% of the 14.8 ...
(Date:5/29/2015)... 2015 To compile the list, the ... that have several awards for clinical and general excellence. ... stood out to them in terms of overall excellence, ... , The 50 Great Health Systems to Know 2015 ... (Altamonte Springs, Fla.) , Advocate Health Care (Downers Grove, ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 World Patent ... products, announces that it has signed a 10 year ... patent that aims to let people learn about any ... real time. , "This is an exciting day for ... said Scott J. Cooper, CEO and Creative Director of ...
(Date:5/29/2015)... Mediaplanet has joined forces with Raw Elements ... importance of proper sun protection. The print component of ... circulation of approximately 250,000 copies and an estimated readership ... through a vast social media strategy, and across a ... explore the digital version of the campaign, click ...
(Date:5/29/2015)... BC (PRWEB) May 29, 2015 Shaila ... & Sports Rehab, has recently stated in a new ... and suffer”. Urinary Continence is commonly seen as a ... before seeking help. Expert physiotherapists like Shaila Jiwa try ... the condition. , Incontinence is a condition that ...
Breaking Medicine News(10 mins):Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 2Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 3Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 4Health News:Becker's Hospital Review Names 50 Great Health Systems to Know 2Health News:Becker's Hospital Review Names 50 Great Health Systems to Know 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 4Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 5Health News:Patients of Urinary Incontinence Should Not "Hide And Suffer," States Physiotherapist from Burnaby Physiotherapy Clinic 2
... have allegedly found inconsistencies in President Bush's AIDS-fighting program//, ... difficult, to gauge the success of the programme. ... AIDS program, valued at $15-billion has not enabled a ... has assisted. The Bush administration is now trying to ...
... of dioxin in a U.S. beef consignment to Seoul, according ... and the American beef industry are still unconvinced about the ... which is higher than Korea’s 5-picogram level. ,USDA ... we found 6.26 picograms of dioxin [in our samples], public ...
... Congress, held in Boston earlier this year,// a trio ... were awarded the world transplant community's highest honor: The ... mark outstanding new research that will lead to tomorrow's ... is a special issue dedicated to the World Transplant ...
... resulting from excessive binge-alcohol drinking can be prevented ... (ibandronate), a Loyola University Health System study shows. ... which is detrimental to youngsters and young adults, ... osteoporotic post-menopausal women,” said principal study investigator Dr. ...
... and health facilities has revealed that 14 inmates have died// ... deaths are believed to have resulted from treatment errors and ... reported that the jail infrastructure lacks adequate doctors, nurses and ... medical conditions ranging from hernia to heart disease. ...
... times when most people just don’t move away from ... helps them to fulfill psychological needs. ,University of ... and enquired from 1000 gamers their motivation to keep ... Emotion this month suggest that people enjoy video games ...
Cached Medicine News:Health News:Highlights from World Transplant Congress 2Health News:Highlights from World Transplant Congress 3Health News:Vitamin D or Anti-osteoporosis Drug Reduces Bone Loss from Binge Drinking 2Health News:Why People are Addicted to Video Games? 2
The CGRL is a Wide Angle Contact Glass designed for laser photocoagulation and diagnosis of the retina....
For use with Slitlamps which have a smaller distance between the eye and the reduction prism than the Haag-Streit 900. Designed to work with argon/YAG Lasers....
... capture and management system that acquires extremely ... Angiography images. It interfaces with most current ... from any ophthalmic device with video, digital ... quality colour Retinal Images from non-mydriatic fundus ...
... that replaces the old technology, the automated ... bringing virtually unlimited charts to the patient ... at the practitioners finger tips. The STIMULi ... optotypes, associated vision tests and fixation devices ...
Medicine Products: